Latest Regulatory News

Imugene Limited and JW Therapeutics have launched a strategic collaboration to combine oncolytic virus and CAR-T cell therapies, aiming to tackle refractory solid tumors through a pioneering 'mark and kill' approach.

Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.

Native Mineral Resources has surpassed 1,000 ounces of gold production at its Blackjack Gold Project, marking a key transition to steady-state operations. The company is also advancing critical infrastructure and environmental approvals to support future growth.

EMVision Medical Devices has begun a pivotal aeromedical study with the Royal Flying Doctor Service to test its portable First Responder brain scanner in remote emergency settings. The trial aims to validate device usability and workflow integration ahead of commercial rollout.

Right Resources has confirmed extensive high-grade gold mineralisation along a 1km strike at its Pilot Project in New South Wales, with maiden drilling now in progress to validate these promising findings.

Kingsgate Consolidated and the Thai government have mutually agreed to terminate a long-standing arbitration under TAFTA, signaling renewed cooperation and promising benefits for the Chatree gold and silver mine.

Provaris Energy’s 2025 AGM highlights strategic progress in hydrogen and CO2 storage technologies, focusing on European market expansion and a refined licensing business model.

New Zealand King Salmon Investments Limited has revealed a significant 44% decline in revenue alongside a net loss of NZD 6.3 million for the eight months ending September 2025, signaling challenges ahead for the seafood producer.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Redivium Limited has withdrawn its planned European Green Bond issuance amid challenging market conditions and an ongoing ASX suspension, despite securing conditional investor commitments. The company signals a future return to green debt markets when conditions improve.

Redivium Limited has postponed the completion of its UK lithium-ion battery recycling feasibility study to Q2 2026 due to a site relocation requiring updated environmental assessments. Meanwhile, its European projects in Czechia and Romania continue to advance steadily.

Redivium Limited is advancing a recapitalisation strategy with Australian investors to meet ASX requirements and resume trading after a prolonged suspension.